Binding and recognition between p16INK4a and CDK4 or CDK6 proteins are mediated primarily by hydrogen-bond networks (Russo et al, 1998), with several of the residues that participate in these interactions being mutated in cancer (Figure 1). The gene discussed is CDKN2A; the disease is cancer.